Literature DB >> 18055714

Association of elevated C-reactive protein levels with an impaired prognosis in patients with surgically treated endometrial cancer.

Maximilian Schmid1, Alois Schneitter, Stefan Hinterberger, Julia Seeber, Alexander Reinthaller, Lukas Hefler.   

Abstract

OBJECTIVE: To evaluate whether C-reactive protein (CRP) serum levels are associated with prognosis in surgically treated endometrial cancer.
METHODS: In the present multicenter study, CRP serum levels were measured preoperatively in 403 surgically staged patients with endometrioid endometrial cancer. Results were correlated to clinical data.
RESULTS: The mean (standard deviation) serum CRP level in patients with endometrial cancer was 1.0 (1.8) mg/dL. Serum CRP levels were associated with tumor stage (P=.01), but not with tumor grade (P=.8), lymph node involvement (P=.8), and age at diagnosis (P=.9). In a univariable survival analysis, serum CRP levels, tumor stage, tumor grade, and age at diagnosis were associated with disease-free and overall survival (all P <.001). In a multivariable Cox regression model, serum CRP levels (P=.001, P=.004), tumor stage (P <.001, P <.001), tumor grade (P=.02, P=.009), and age at diagnosis (P=.002, P=.001) were independent prognostic factors for disease-free and overall survival.
CONCLUSION: Our results suggest that elevated serum CRP levels are associated with a less favorable prognosis in patients with surgically treated endometrial cancer. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18055714     DOI: 10.1097/01.AOG.0000292085.50987.f2

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  22 in total

1.  Treating endometrial cancer.

Authors:  Athol Kent
Journal:  Rev Obstet Gynecol       Date:  2008

2.  C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): confirmatory results.

Authors:  Renee C Prins; Brooks L Rademacher; Solange Mongoue-Tchokote; Joshi J Alumkal; Julie N Graff; Kristine M Eilers; Tomasz M Beer
Journal:  Urol Oncol       Date:  2010-03-06       Impact factor: 3.498

3.  Evaluation of CD4+:CD8+ Ratio in Patients With Cervical Cancer and the Levels of Inflammatory Markers.

Authors:  Magdi M Salih; Mazen Almehmadi; Alaa Shafie; Abdulaziz Alsharif; Naif Alsiwiehri; Ahmad El-Askary; Khalid Alzahrani; Abdulelah Aljuaid; Osama Abdulaziz; Amani Ahmed Alrehaili; Abdulraheem A Almalki; Hassan Swed Alzahrani; Mustafa Halawi; Safar Almalki; Ebtisam Alosimi; Amal F Gharib
Journal:  In Vivo       Date:  2022 Sep-Oct       Impact factor: 2.406

4.  The Influence of the Pretreatment Immune State on Response to Radiation Therapy in High-Risk Prostate Cancer: A Validation Study From NRG/RTOG 0521.

Authors:  William A Hall; Theodore G Karrison; Seth A Rosenthal; Mahul B Amin; Leonard G Gomella; James A Purdy; A Oliver Sartor; Jeff M Michalski; Mark G Garzotto; Carmen Bergom; Ashesh B Jani; Colleen A F Lawton; Jeffry P Simko; Joan K Moore; Elizabeth M Gore; W Robert Lee; Paul L Nguyen; Brita L Danielson; Howard M Sandler; Felix Y Feng
Journal:  Int J Radiat Oncol Biol Phys       Date:  2022-06-05       Impact factor: 8.013

5.  The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial.

Authors:  V Seebacher; S Polterauer; C Grimm; H Husslein; H Leipold; K Hefler-Frischmuth; C Tempfer; A Reinthaller; L Hefler
Journal:  Br J Cancer       Date:  2010-02-16       Impact factor: 7.640

6.  Postdiagnosis C-reactive protein and breast cancer survivorship: findings from the WHEL study.

Authors:  Adriana Villaseñor; Shirley W Flatt; Catherine Marinac; Loki Natarajan; John P Pierce; Ruth E Patterson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-11-12       Impact factor: 4.254

7.  Prognostic significance of gamma-glutamyltransferase in patients with endometrial cancer: a multi-centre trial.

Authors:  V Seebacher; S Polterauer; C Grimm; J Rahhal; G Hofstetter; E-M Bauer; H Husslein; H Leipold; C Marth; A Reinthaller; N Concin
Journal:  Br J Cancer       Date:  2012-02-07       Impact factor: 7.640

8.  Elevated pre-treatment levels of plasma C-reactive protein are associated with poor prognosis after breast cancer: a cohort study.

Authors:  Kristine H Allin; Børge G Nordestgaard; Henrik Flyger; Stig E Bojesen
Journal:  Breast Cancer Res       Date:  2011-06-03       Impact factor: 6.466

9.  Sex Hormones, Insulin, and Insulin-like Growth Factors in Recurrence of High-Stage Endometrial Cancer.

Authors:  Gloria S Huang; Marc J Gunter; Melissa A Merritt; Howard D Strickler; Alan D Hutson; Mark H Einstein; Thomas E Rohan; Xiaonan Xue; Mark E Sherman; Louise A Brinton; Herbert Yu; David S Miller; Nilsa C Ramirez; Heather A Lankes; Michael J Birrer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-02-23       Impact factor: 4.090

10.  Preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma.

Authors:  Dan Wang; Jia-Xin Yang; Dong-Yan Cao; Xi-Run Wan; Feng-Zhi Feng; Hui-Fang Huang; Keng Shen; Yang Xiang
Journal:  Onco Targets Ther       Date:  2013-03-16       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.